336 related articles for article (PubMed ID: 15177686)
1. Altered replication timing of the HIRA/Tuple1 locus in the DiGeorge and Velocardiofacial syndromes.
D'Antoni S; Mattina T; Di Mare P; Federico C; Motta S; Saccone S
Gene; 2004 May; 333():111-9. PubMed ID: 15177686
[TBL] [Abstract][Full Text] [Related]
2. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
[TBL] [Abstract][Full Text] [Related]
3. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes.
Daw SC; Taylor C; Kraman M; Call K; Mao J; Schuffenhauer S; Meitinger T; Lipson T; Goodship J; Scambler P
Nat Genet; 1996 Aug; 13(4):458-60. PubMed ID: 8696341
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of a novel gene from the DiGeorge chromosomal region that encodes for a mediator subunit.
Berti L; Mittler G; Przemeck GK; Stelzer G; Günzler B; Amati F; Conti E; Dallapiccola B; Hrabé de Angelis M; Novelli G; Meisterernst M
Genomics; 2001 Jun; 74(3):320-32. PubMed ID: 11414760
[TBL] [Abstract][Full Text] [Related]
5. CATCH 22 syndrome: report of 7 infants with follow-up data and review of the recent advancements in the genetic knowledge of the locus 22q11.
Sergi C; Serpi M; Müller-Navia J; Schnabel PA; Hagl S; Otto HF; Ulmer HE
Pathologica; 1999 Jun; 91(3):166-72. PubMed ID: 10536461
[TBL] [Abstract][Full Text] [Related]
6. Characterization and mutation analysis of goosecoid-like (GSCL), a homeodomain-containing gene that maps to the critical region for VCFS/DGS on 22q11.
Funke B; Saint-Jore B; Puech A; Sirotkin H; Edelmann L; Carlson C; Raft S; Pandita RK; Kucherlapati R; Skoultchi A; Morrow BE
Genomics; 1997 Dec; 46(3):364-72. PubMed ID: 9441739
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 22q11.2 microdeletions in velocardiofacial syndrome patients with widely variable manifestations.
Ravnan JB; Chen E; Golabi M; Lebo RV
Am J Med Genet; 1996 Dec; 66(3):250-6. PubMed ID: 8985481
[TBL] [Abstract][Full Text] [Related]
8. Positional mapping of loci in the DiGeorge critical region at chromosome 22q11 using a new marker (D22S183).
Mulder MP; Wilke M; Langeveld A; Wilming LG; Hagemeijer A; van Drunen E; Zwarthoff EC; Riegman PH; Deelen WH; van den Ouweland AM
Hum Genet; 1995 Aug; 96(2):133-41. PubMed ID: 7635459
[TBL] [Abstract][Full Text] [Related]
9. Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR).
McQuade L; Christodoulou J; Budarf M; Sachdev R; Wilson M; Emanuel B; Colley A
Am J Med Genet; 1999 Sep; 86(1):27-33. PubMed ID: 10440825
[TBL] [Abstract][Full Text] [Related]
10. Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11.
Kelly D; Goldberg R; Wilson D; Lindsay E; Carey A; Goodship J; Burn J; Cross I; Shprintzen RJ; Scambler PJ
Am J Med Genet; 1993 Feb; 45(3):308-12. PubMed ID: 8434616
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Registry screening for DiGeorge Critical Region deletion using loss of heterozygosity analysis.
Katzman PJ; Smoot LB; Cox GF
Pediatr Dev Pathol; 2006; 9(4):266-79. PubMed ID: 16944986
[TBL] [Abstract][Full Text] [Related]
12. Is the autosomal dominant Optiz GBBB syndrome part of the DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2?
Wulfsberg EA
Am J Med Genet; 1996 Aug; 64(3):523-4. PubMed ID: 8862634
[No Abstract] [Full Text] [Related]
13. Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome.
Guris DL; Fantes J; Tara D; Druker BJ; Imamoto A
Nat Genet; 2001 Mar; 27(3):293-8. PubMed ID: 11242111
[TBL] [Abstract][Full Text] [Related]
14. Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions.
Lindsay EA; Goldberg R; Jurecic V; Morrow B; Carlson C; Kucherlapati RS; Shprintzen RJ; Baldini A
Am J Med Genet; 1995 Jul; 57(3):514-22. PubMed ID: 7677167
[TBL] [Abstract][Full Text] [Related]
15. Kabuki syndrome is not caused by a microdeletion in the DiGeorge/velocardiofacial chromosomal region within 22q 11.2.
Li M; Zackai EH; Niikawa N; Kaplan P; Driscoll DA
Am J Med Genet; 1996 Oct; 65(2):101-3. PubMed ID: 8911598
[TBL] [Abstract][Full Text] [Related]
16. Cloning and comparative mapping of the DiGeorge syndrome critical region in the mouse.
Sutherland HF; Kim UJ; Scambler PJ
Genomics; 1998 Aug; 52(1):37-43. PubMed ID: 9740669
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite DNA markers detects 95% of chromosome 22q11 deletions.
Bonnet D; Cormier-Daire V; Kachaner J; Szezepanski I; Souillard P; Sidi D; Munnich A; Lyonnet S
Am J Med Genet; 1997 Jan; 68(2):182-4. PubMed ID: 9028455
[TBL] [Abstract][Full Text] [Related]
18. Molecular and genetic aspects of DiGeorge/velocardiofacial syndrome.
Driscoll DA
Methods Mol Med; 2006; 126():43-55. PubMed ID: 16930005
[TBL] [Abstract][Full Text] [Related]
19. Independent de novo 22q11.2 deletions in first cousins with DiGeorge/velocardiofacial syndrome.
Saitta SC; Harris SE; McDonald-McGinn DM; Emanuel BS; Tonnesen MK; Zackai EH; Seitz SC; Driscoll DA
Am J Med Genet A; 2004 Jan; 124A(3):313-7. PubMed ID: 14708107
[TBL] [Abstract][Full Text] [Related]
20. CATCH 22: deletion of locus 22q11 in velocardiofacial syndrome, DiGeorge anomaly, and nonsyndromic conotruncal defects.
Hou JW; Wang JK; Tsai WY; Chou CC; Wang TR
J Formos Med Assoc; 1997 Jun; 96(6):419-23. PubMed ID: 9216164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
